Health Condition 1: null- Healthy volunteers and subjects with mild Asthma or COPD.
Conditions
Interventions
Intervention1: Zerostat V spacer with Placebo pMDI: Placebo pMDI (Pressurized Metered Dose Inhaler) with Zerostat-V spacer device used for 3 consecutive inhalation attempts
Intervention2: Placebo: Pla
Sponsors
Cipla Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects and healthy volunteers willing to sign informed consent 2. Subjects and healthy volunteers of 18 years and above 3. Subjects with or without a respiratory condition. Each subject with a respiratory condition (prior experience of using an device) should be matched as far as possible with an individual without a respiratory condition (device naïve) with respect to the age, sex, literacy status etc 4. Subjects with mild Asthma or COPD or healthy volunteer
Exclusion criteria
Exclusion criteria: 1. Subjects already using Zerostat-V spacer prior to start of the study. 2. Subjects with co-ordination problems like Parkinsonâ??s disease, mental illness, tremors etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average time taken for 3 consecutive correct attemptsTimepoint: Average time taken for 3 consecutive correct attempts | — |
Secondary
| Measure | Time frame |
|---|---|
| Confidence, Usability, Preference, Satisfaction assessment.Timepoint: Throughout the study;Type and number of errorsTimepoint: first and second visit | — |
Countries
India
Contacts
Public ContactMs Pallavi Phopale
Cipla Ltd.
Outcome results
None listed